Mastozytose Control Test (MCT) - non-commercial use

The Mastocytosis Control Test (MCT) is an easy-to-use disease-specific tool to assess disease control in patients with cutaneous or indolent systemic mastocytosis. The MCT is a retrospective tool and can be used directly, quickly, and easily during patient presentation. A cut off value helps distinguish patients with poorly controlled disease from patients with well-controlled disease.
MCT was developed at Charité by a team led by PD Dr. Frank Siebenhaar, PD Dr. Karsten Weller and Prof. Dr. Marcus Maurer.

Quick Facts MAS:
Number of items: 5
Recall period: 14 days, retrospective
Suited for: All adult (≥ 18 years) patients with cutaneous or indolent systemic mastocytosis
Domains: Skin, GI tract, other symptoms
Scoring: Total Score (0-20), Cut off: 13 (≥13 corresponds to well controlled disease)
Copyright: Moxie GmbH (www.moxie-gmbh.de)
Terms of use: Free for routine clinical use and non-commercial research, fee requested for use in clinical trials/commercial research.

Publication: coming soon